Orladeyo approved for reimbursement in the Netherlands
Orladeyo is now approved for reimbursement in the Netherlands following a recommendation from healthcare government agency Zorginstituut Nederland. The treatment is used for routine prevention, or prophylaxis, of swelling attacks in people 12 years and older with hereditary angioedema (HAE). With this decision, Orladeyo…